Open Your Free Demat Account
Enjoy low brokerage on delivery trades
The Sai Parenterals IPO is currently open for subscription, and tracking its day-wise status helps understand how different investor categories are participating. Subscription updates across retail, non-institutional, and institutional segments provide a structured view of demand during the IPO period.
This article outlines the IPO’s subscription progress, key issue details, and allocation updates. For complete information on the offering, you can explore the Sai Parenterals IPO page.
The Day 1 subscription status reflects the initial level of participation in the Sai Parenterals IPO. Investor demand is generally tracked across three categories:
Qualified Institutional Buyers (QIBs)
Non-Institutional Investors (NIIs)
Retail Individual Investors (RIIs)
Monitoring category-wise subscription helps in understanding early demand trends. While Day 1 provides an initial snapshot, subscription levels may change as the IPO progresses over multiple days.
Category | Subscription (x) | Shares Offered* | Shares bid for | Total Amt* (₹ Cr.) |
Anchor | 1 | 31,28,485 | 31,28,485 | 122.637 |
QIB (Ex Anchor) | 0.00 | 20,85,659 | 0 | 0 |
NII | 0.09 | 15,64,243 | 1,44,438 | 5.662 |
bNII (> ₹10L) | 0.13 | 10,42,829 | 1,30,492 | 5.115 |
sNII (< ₹10L) | 0.03 | 5,21,414 | 13,946 | 0.547 |
Retail | 0.02 | 36,49,901 | 88,388 | 3.465 |
Total ** | 0.03 | 72,99,803 | 2,32,826 | 9.127 |
Total Applications: 1,632
Note: Subscription figures are updated as of 4.45 pm.
The IPO structure includes important parameters that define how investors can participate. These details provide clarity on the offering:
IPO Date | 24 to 27 Mar, 2026 |
Listing Date | Thu, Apr 2, 2026 |
Face Value | ₹5 per share |
Price Band | ₹372 to ₹392 |
Lot Size | 38 Shares |
Sale Type | Fresh capital cum OFS |
Issue Type | Bookbuilding IPO |
Listing At | BSE, NSE |
Total Issue Size | 1,04,28,288 shares (agg. up to ₹409 Cr) |
These details, along with subscription data, help track the progress of the IPO and understand its timeline.
The proceeds from the IPO are typically allocated toward business and operational requirements. Based on disclosures, utilisation may include:
Expansion of manufacturing or operational capacity
Investment in infrastructure and facilities
Repayment or prepayment of borrowings
Working capital requirements
General corporate purposes
The detailed utilisation breakdown will be specified in the official offer documents.
Anchor investor allocation is disclosed prior to the IPO opening and indicates institutional participation in the issue.
Particulars | Details |
Anchor Investor Portion | 30% |
Number of Anchor Investors | Data to be updated |
Allocation Price | 392.00 |
Total Amount Allocated (Cr.) | 122.64 |
Click here to check out recently closed IPO
The Sai Parenterals IPO subscription status provides a structured view of investor participation during the offer period. Day-wise updates across categories help track how demand evolves over time.
As subscription figures and allocation details are updated, readers can refer to official IPO documents and sources for complete and accurate information.
Interested in more opportunities? Check out our Upcoming IPO section for new listings and don’t forget to check your IPO allotment status for Powerica IPO.
Disclaimer :
Investments in the securities market are subject to market risk, read all related documents carefully before investing. This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.
The information on this website is provided on "AS IS" basis. Bajaj Broking (BFSL) does not warrant the accuracy of the information given herein, either expressly or impliedly, for any particular purpose and expressly disclaims any warranties of merchantability or suitability for any particular purpose. While BFSL strives to ensure accuracy, it does not guarantee the completeness, reliability, or timeliness of the information. Users are advised to independently verify details and stay updated with any changes. The securities are quoted as an example and not as a recommendation. Past performance is not necessarily a guide to future performance.
The information provided on this website is for general informational purposes only and is subject to change without prior notice. BFSL shall not be responsible for any consequences arising from reliance on the information provided herein and shall not be held responsible for all or any actions that may subsequently result in any loss, damage and or liability. Interest rates, fees, and charges etc., are revised from time to time, for the latest details please refer to our Pricing page.
Neither the information, nor any opinion contained in this website constitutes a solicitation or offer by BFSL or its affiliates to buy or sell any securities, futures, options or other financial instruments or provide any investment advice or service.
BFSL is acting as distributor for non-broking products/ services such as IPO, Mutual Fund, Insurance, PMS, and NPS. These are not Exchange Traded Products. For more details on risk factors, terms and conditions please read the sales brochure carefully before investing.
Content Partner - Dalal Street Investment Journal Wealth Advisory Private Limited
This article is for educational purposes only and should not be considered investment advice. Market investments are subject to risks. DSIJ Wealth Advisory Private Limited is a SEBI-registered Research Analyst (Reg. No: INH000006396) and Investment Adviser (Reg. No: INA000001142). Please consult your financial adviser before investing.
For more disclaimer, check here : https://www.bajajbroking.in/disclaimer
Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading